1 | 4-Aminosalicylic acid extended release granules | [1] Aminosalicylic acid Aminosalicylic acid | [1] D00162
D00162
| - | - | [1] 96 96 |
2 | 750 mg metformin and 7.5 g L-citrulline daily p.o. (Synonym: METFORMIN HYDROCHLORIDE EXTENDED RELEASE) | [2] Citrulline Citrulline, Metformin (Synonym: Metformin Hydrochloride Extended Release) | [3] D00944
D00944
(Name: METFORMIN HYDROCHLORIDE EXTENDED RELEASE),
D04966
,
D07706
| [2] PRKAA1 PRKAA1, PRKAA2 💬 | [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [1] 113 113 |
3 | Aceneuramic Acid Extended-Release | [1] Aceneuramic acid Aceneuramic acid | [1] D11016
D11016
| - | - | [1] 30 30 |
4 | Aceneuramic acid extended-release (Ace-ER) | [1] Aceneuramic acid Aceneuramic acid | [1] D11016
D11016
| - | - | [1] 30 30 |
5 | Aceneuramic Acid Extended-Release Tablets | [1] Aceneuramic acid Aceneuramic acid | [1] D11016
D11016
| - | - | [1] 30 30 |
6 | ADS-5102 (extended release amantadine HCl) | [1] Amantadine Amantadine | [2] D00777
D00777
,
D07441
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | [20] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 6 6 |
7 | Advagraf prolonged-release hard capsules | [2] Manganese citrate Manganese citrate (Synonym: Release), Tacrolimus | [2] D00107
D00107
,
D08556
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 299 299 |
8 | ALKS 8700 Delayed Release (DR) | [1] Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | [1] 13 13 |
9 | ALKS 8700 Delayed Release (DR) Capsule | [1] Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | [1] 13 13 |
10 | Amantadine HCl Extended Release | [1] Amantadine Amantadine | [2] D00777
D00777
,
D07441
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | [20] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 6 6 |
11 | Amantadine HCl Extended Release Capsule | [1] Amantadine Amantadine | [2] D00777
D00777
,
D07441
| [5] GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | [20] Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | [1] 6 6 |
12 | Antioxidant plus Pregabalin (Synonym: PREGABALIN EXTENDED RELEASE) | [1] Pregabalin Pregabalin (Synonym: Pregabalin Extended Release) | [1] D02716
D02716
(Name: PREGABALIN EXTENDED RELEASE) | [4] CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 | [7] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬 | [1] 298 298 |
13 | APRISO 375 mg extended-release capsules | [1] Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | [1] 97 97 |
14 | Arbaclofen Extended Release Tablets | [1] Arbaclofen Arbaclofen | [1] D09791
D09791
| [2] GABBR1 GABBR1, GABBR2 💬 | [7] Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | [1] 13 13 |
15 | Asacol (mesalamine) Delayed-release Tablets | [1] Mesalazine Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | [1] D00377
D00377
| - | - | [1] 97 97 |
16 | Asacol Delayed Release Tablets | [2] Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | [1] D00377
D00377
| - | - | [1] 97 97 |
17 | Asacol Delayed-Release Tablets | [2] Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | [1] D00377
D00377
| - | - | [1] 97 97 |
18 | AZD3241 Extended release tablets 100 mg | [1] Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | [1] 6 6 |
19 | AZD3241 Extended release tablets 25 mg | [1] Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | [1] 6 6 |
20 | Beraprost Sodium 314d Modified Release Tablets | [1] Beraprost Beraprost | [1] D02720
D02720
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 |
21 | Beraprost Sodium Modified Release | [1] Beraprost Beraprost | [1] D02720
D02720
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 |
22 | Budesonide 6 mg prolonged-release capsule, hard (BUX-PVII prototype) | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 |
23 | Budesonide 6 mg prolonged-release capsules, hard (BUX-PVII prototype) | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 |
24 | Budesonide 9 mg prolonged-release capsule, hard (BUX-PVII prototype) | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 |
25 | Budesonide 9 mg prolonged-release capsules, hard (BUX-PVII prototype) | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 |
26 | Bupropion (Synonym: BUPROPION HYDROCHLORIDE EXTENDED RELEASE) | [1] Bupropion Bupropion (Synonym: Contrave Extended-Release) | [3] D00817
D00817
(Name: BUPROPION HYDROCHLORIDE EXTENDED RELEASE),
D07591
,
D07938
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [5] 8 8, 18, 21, 96, 171 |
27 | Bupropion & Citalopram (Synonym: BUPROPION HYDROCHLORIDE EXTENDED RELEASE) | [2] Bupropion Bupropion (Synonym: Contrave Extended-Release), Citalopram | [5] D00817
D00817
(Name: BUPROPION HYDROCHLORIDE EXTENDED RELEASE),
D00822
,
D07591
,
D07704
,
D07938
| [3] SLC6A2 SLC6A2, SLC6A3, SLC6A4 💬 | [8] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 18 18 |
28 | Bupropion Hydrochloride (Synonym: BUPROPION HYDROCHLORIDE EXTENDED RELEASE) | [1] Bupropion Bupropion (Synonym: Contrave Extended-Release) | [3] D00817
D00817
(Name: BUPROPION HYDROCHLORIDE EXTENDED RELEASE),
D07591
,
D07938
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 171 171 |
29 | Bydureon 2 mg powder and solvent for prolonged-release suspension | [2] Exenatide Exenatide, Manganese citrate (Synonym: Release) | [1] D04121
D04121
| [1] GLP1R GLP1R 💬 | [3] Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 6 6 |
30 | Carbidopa and Levodopa Controlled Release Tablets | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
31 | Carbidopa/Levodopa, immediate release | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
32 | Combination of Minocycline and MTX or MTX alone (Synonym: MINOLIRA EXTENDED RELEASE) | [1] Minocycline Minocycline (Synonym: Minolira Extended Release) | [2] D00850
D00850
(Name: MINOLIRA EXTENDED RELEASE),
D05045
| - | - | [1] 46 46 |
33 | Comparator: diclofenac (Synonym: DICLOFENAC SODIUM DELAYED RELEASE) | [1] Diclofenac Diclofenac (Synonym: Diclofenac Sodium Extended-Release) | [3] D00903
D00903
,
D00904
(Name: DICLOFENAC SODIUM DELAYED RELEASE),
D07816
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 |
34 | Comparator: Diclofenac sodium (Synonym: DICLOFENAC SODIUM DELAYED RELEASE) | [1] Diclofenac Diclofenac (Synonym: Diclofenac Sodium Extended-Release) | [3] D00903
D00903
,
D00904
(Name: DICLOFENAC SODIUM DELAYED RELEASE),
D07816
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 |
35 | Continuous Release Dopamine Agonists | [1] Dopamine Dopamine | [2] D00633
D00633
,
D07870
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
36 | Controlled-release levodopa / carbidopa | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
37 | Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone) | [7] Acetate Acetate, Cortisone, Cortisone acetate, Dexamethasone, Hydrocortisone, Prednisolone, Prednisone | [21] D00088
D00088
,
D00292
,
D00472
,
D00473
,
D00973
,
D00975
,
D00980
,
D00981
,
D00982
,
D01239
,
D01510
,
D01615
,
D01632
,
D01948
,
D01998
,
D02156
,
D02174
,
D02591
,
D02592
,
D03301
,
D07749
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 |
38 | Cystagon (cysteamine bitartrate) immediate-release capsules | [1] Cysteamine Cysteamine (Synonym: PROCYSBI Delayed-release) | [2] D03634
D03634
,
D03635
| - | - | [1] 299 299 |
39 | Cysteamine Bitartrate Delayed-release Capsules | [1] Cysteamine Cysteamine (Synonym: PROCYSBI Delayed-release) | [2] D03634
D03634
,
D03635
| - | - | [1] 19 19 |
40 | Cysteamine Bitartrate Delayed-release Capsules (RP103) | [1] Cysteamine Cysteamine (Synonym: PROCYSBI Delayed-release) | [2] D03634
D03634
,
D03635
| - | - | [1] 19 19 |
41 | D-methylphenidate (Synonym: METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE) | [1] Methylphenidate Methylphenidate (Synonym: JORNAY PM Extended-Release) | [2] D01296
D01296
(Name: METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),
D04999
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 84 84 |
42 | Deferiprone 600 mg delayed release tablet | [1] Deferiprone Deferiprone | [1] D07416
D07416
| - | - | [1] 6 6 |
43 | Delayed and extended release mesalazine | [1] Mesalazine Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | [1] D00377
D00377
| - | - | [1] 97 97 |
44 | Delayed Release 6 mercaptopurine | [1] Mercaptopurine Mercaptopurine | [2] D00161
D00161
,
D04931
| [1] HPRT1 HPRT1 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [1] 96 96 |
45 | Delayed Release 6MP or Calcitriol vs. Purinethol | [1] Calcitriol Calcitriol | [1] D00129
D00129
| [1] VDR VDR 💬 | [5] Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | [1] 96 96 |
46 | Diazoxide choline controlled-release tablet | [2] Choline Choline (Synonym: Complete Multivitamins and Minerals Tablets Timed Release), Diazoxide | [2] D00294
D00294
,
D07690
| [2] ABCC8 ABCC8, KCNJ11 💬 | [4] ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | [1] 193 193 |
47 | Diclofenac (Synonym: DICLOFENAC SODIUM DELAYED RELEASE) | [1] Diclofenac Diclofenac (Synonym: Diclofenac Sodium Extended-Release) | [3] D00903
D00903
,
D00904
(Name: DICLOFENAC SODIUM DELAYED RELEASE),
D07816
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [5] 13 13, 34, 46, 78, 271 |
48 | Diclofenac + Omeprazole (Synonym: DICLOFENAC SODIUM DELAYED RELEASE) | [2] Diclofenac Diclofenac (Synonym: Diclofenac Sodium Extended-Release), Omeprazole (Synonym: TopCare Omeprazole delayed release) | [7] D00455
D00455
,
D00903
,
D00904
(Name: DICLOFENAC SODIUM DELAYED RELEASE),
D01207
,
D05259
,
D05261
,
D07816
| [4] ATP4A ATP4A, ATP4B, PTGS1, PTGS2 💬 | [26] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 |
49 | Diclofenac 50 milligrams (Synonym: DICLOFENAC SODIUM DELAYED RELEASE) | [1] Diclofenac Diclofenac (Synonym: Diclofenac Sodium Extended-Release) | [3] D00903
D00903
,
D00904
(Name: DICLOFENAC SODIUM DELAYED RELEASE),
D07816
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 |
50 | Diclofenac Sodium (Synonym: DICLOFENAC SODIUM DELAYED RELEASE) | [1] Diclofenac Diclofenac (Synonym: Diclofenac Sodium Extended-Release) | [3] D00903
D00903
,
D00904
(Name: DICLOFENAC SODIUM DELAYED RELEASE),
D07816
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [2] 34 34, 46 |
51 | Diclofenac sodium topical gel (Synonym: DICLOFENAC SODIUM DELAYED RELEASE) | [1] Diclofenac Diclofenac (Synonym: Diclofenac Sodium Extended-Release) | [3] D00903
D00903
,
D00904
(Name: DICLOFENAC SODIUM DELAYED RELEASE),
D07816
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 13 13 |
52 | Diclofenac SR (Synonym: DICLOFENAC SODIUM DELAYED RELEASE) | [1] Diclofenac Diclofenac (Synonym: Diclofenac Sodium Extended-Release) | [3] D00903
D00903
,
D00904
(Name: DICLOFENAC SODIUM DELAYED RELEASE),
D07816
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 271 271 |
53 | Diltiazem (Synonym: DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE) | [1] Diltiazem Diltiazem (Synonym: Diltiazem Hydrochloride Extended-Release) | [3] D00616
D00616
(Name: DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE),
D03830
,
D07845
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [3] 51 51, 58, 86 |
54 | Diltiazem Gel 2% (Synonym: DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE) | [1] Diltiazem Diltiazem (Synonym: Diltiazem Hydrochloride Extended-Release) | [3] D00616
D00616
(Name: DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE),
D03830
,
D07845
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 |
55 | Diltiazem Hydrochloride (Synonym: DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE) | [1] Diltiazem Diltiazem (Synonym: Diltiazem Hydrochloride Extended-Release) | [3] D00616
D00616
(Name: DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE),
D03830
,
D07845
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
56 | Dual release hydrocortisone (plenadren) | [1] Hydrocortisone Hydrocortisone | [1] D00088
D00088
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 |
57 | Efmody 10 mg modified release hard capsules | [1] Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | [1] 81 81 |
58 | Efmody 5 mg modified release hard capsules | [1] Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | [1] 81 81 |
59 | Epilim Chrono 200 Controlled Released tablets | - | - | - | - | [1] 256 256 |
60 | Epilim Chrono 300 Controlled Released tablets | - | - | - | - | [1] 256 256 |
61 | Epilim Chrono 500 Controlled Released tablets | - | - | - | - | [1] 256 256 |
62 | Exenatide extended release 2mg (Bydureon) | [1] Exenatide Exenatide | [1] D04121
D04121
| [1] GLP1R GLP1R 💬 | [3] Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 6 6 |
63 | Extended release dipyridamole 200mg/aspirin 25mg | [2] Acetylsalicylic acid Acetylsalicylic acid (Synonym: Aspirin Coated for Delayed Release Regular Strength), Dipyridamole (Synonym: Aspirin and Extended-release Dipyridamole) | [2] D00109
D00109
,
D00302
| [4] PDE4A PDE4A, PDE5A, PTGS1, PTGS2 💬 | [28] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, Morphine addiction, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Purine metabolism, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 49 49 |
64 | Extended release fampridine | [1] Dalfampridine Dalfampridine | [1] D04127
D04127
| [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [1] 13 13 |
65 | Extended-release oxycodone | [1] Oxycodone Oxycodone (Synonym: Oxycodone HCl Controlled-Release) | [3] D03783
D03783
,
D05312
,
D05462
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 13 13 |
66 | Extended-release quetiapine fumarate | [1] Quetiapine Quetiapine (Synonym: Quetiapine Extended Release) | [2] D00458
D00458
,
D08456
| [2] DRD2 DRD2, HTR2A 💬 | [11] Alcoholism Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬 | [1] 13 13 |
67 | Fampyra 10 mg prolonged-release tablets | [2] Dalfampridine Dalfampridine, Manganese citrate (Synonym: Release) | [1] D04127
D04127
| [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [1] 13 13 |
68 | Fampyra 10mg prolonged release tablets | [2] Dalfampridine Dalfampridine, Manganese citrate (Synonym: Release) | [1] D04127
D04127
| [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [1] 13 13 |
69 | Firategrast immediate release tablet | [1] Firategrast Firategrast | [1] D06590
D06590
| [1] ITGA4 ITGA4 💬 | [14] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | [1] 13 13 |
70 | Firategrast modified release tablet | [1] Firategrast Firategrast | [1] D06590
D06590
| [1] ITGA4 ITGA4 💬 | [14] Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | [1] 13 13 |
71 | Glatiramer acetate with minocycline (Synonym: MINOLIRA EXTENDED RELEASE) | [3] Acetate Acetate, Glatiramer, Minocycline (Synonym: Minolira Extended Release) | [3] D00850
D00850
(Name: MINOLIRA EXTENDED RELEASE),
D04318
,
D05045
| [20] HLA-A HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 | [32] Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | [1] 13 13 |
72 | Glucophage (metformin) (Synonym: METFORMIN HYDROCHLORIDE EXTENDED RELEASE) | [1] Metformin Metformin (Synonym: Metformin Hydrochloride Extended Release) | [2] D00944
D00944
(Name: METFORMIN HYDROCHLORIDE EXTENDED RELEASE),
D04966
| [2] PRKAA1 PRKAA1, PRKAA2 💬 | [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [2] 46 46, 75 |
73 | Guanfacine (Synonym: GUANFACINE EXTENDED-RELEASE) | [1] Guanfacine Guanfacine (Synonym: Guanfacine Extended-Release) | [2] D00606
D00606
(Name: GUANFACINE EXTENDED-RELEASE),
D08031
| [1] ADRA2A ADRA2A 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 193 193 |
74 | Guanfacine extended release (GXR) | [1] Guanfacine Guanfacine (Synonym: Guanfacine Extended-Release) | [2] D00606
D00606
(Name: GUANFACINE EXTENDED-RELEASE),
D08031
| [1] ADRA2A ADRA2A 💬 | [2] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 193 193 |
75 | Hydrocortisone Modified Release Capsules | [1] Hydrocortisone Hydrocortisone | [1] D00088
D00088
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 |
76 | IBD98-M Delayed-release Capsules | [1] Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | [1] 97 97 |
77 | Immediate release carbidopa/levodopa | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
78 | Immediate Release carbidopa/levodopa 10/100 mg | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
79 | Immediate Release carbidopa/levodopa 25/100 mg | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
80 | Indomethacin (Synonym: INDOMETHACIN EXTENDED-RELEASE) | [1] Indomethacin Indomethacin (Synonym: Indomethacin extended-release) | [3] D00141
D00141
(Name: INDOMETHACIN EXTENDED-RELEASE),
D01565
,
D02110
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [3] 225 225, 271, 298 |
81 | Intravenous Infusion of Diclofenac Sodium (Synonym: DICLOFENAC SODIUM DELAYED RELEASE) | [1] Diclofenac Diclofenac (Synonym: Diclofenac Sodium Extended-Release) | [3] D00903
D00903
,
D00904
(Name: DICLOFENAC SODIUM DELAYED RELEASE),
D07816
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 78 78 |
82 | KVD824 300 mg Modified Release Tablets | [1] Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | [1] 65 65 |
83 | L-Citrulline and Metformin & L-Citrulline (Synonym: METFORMIN HYDROCHLORIDE EXTENDED RELEASE) | [2] Citrulline Citrulline, Metformin (Synonym: Metformin Hydrochloride Extended Release) | [3] D00944
D00944
(Name: METFORMIN HYDROCHLORIDE EXTENDED RELEASE),
D04966
,
D07706
| [2] PRKAA1 PRKAA1, PRKAA2 💬 | [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [1] 113 113 |
84 | Lamotrigine (Synonym: LAMOTRIGINE EXTENDED RELEASE) | [1] Lamotrigine Lamotrigine (Synonym: Lamotrigine Extended Release) | [1] D00354
D00354
(Name: LAMOTRIGINE EXTENDED RELEASE) | [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [5] 13 13, 34, 38, 114, 144 |
85 | Lamotrigine - generic product (Synonym: LAMOTRIGINE EXTENDED RELEASE) | [1] Lamotrigine Lamotrigine (Synonym: Lamotrigine Extended Release) | [1] D00354
D00354
(Name: LAMOTRIGINE EXTENDED RELEASE) | [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 38 38 |
86 | Lamotrigine 25Mg Oral Tablet, Extended Release | [1] Lamotrigine Lamotrigine (Synonym: Lamotrigine Extended Release) | [1] D00354
D00354
(Name: LAMOTRIGINE EXTENDED RELEASE) | [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 114 114 |
87 | Lamotrigine dispers (Synonym: LAMOTRIGINE EXTENDED RELEASE) | [1] Lamotrigine Lamotrigine (Synonym: Lamotrigine Extended Release) | [1] D00354
D00354
(Name: LAMOTRIGINE EXTENDED RELEASE) | [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 34 34 |
88 | Lamotrigine extended release tablets | [1] Lamotrigine Lamotrigine (Synonym: Lamotrigine Extended Release) | [1] D00354
D00354
(Name: LAMOTRIGINE EXTENDED RELEASE) | [5] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [3] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | [1] 13 13 |
89 | Levetiracetam (Synonym: LEVETIRACETAM EXTENDED RELEASE) | [1] Levetiracetam Levetiracetam (Synonym: Levetiracetam Extended Release) | [1] D00709
D00709
(Name: LEVETIRACETAM EXTENDED RELEASE) | [1] SV2A SV2A 💬 | [1] ECM-receptor interaction ECM-receptor interaction 💬 | [5] 2 2, 4, 6, 13, 307 |
90 | Levodopa carbidopa (LC) oral encapsulated immediate release (IR) tablets | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
91 | Levodopa CR (controlled release) | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
92 | Levodopa-carbidopa (LC) oral encapsulated immediate release (IR) tablets | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
93 | Levodopa-carbidopa Immediate Release (LC-IR) Tablets | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
94 | Levodopa-Carbidopa Multilayer Extended Release Tablet | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
95 | Lodotra (delayed release prednisolone) | [1] Prednisolone Prednisolone | [8] D00472
D00472
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 41 41 |
96 | Lovastatin, then Minocycline/Lovastatin (Synonym: MINOLIRA EXTENDED RELEASE) | [2] Lovastatin Lovastatin, Minocycline (Synonym: Minolira Extended Release) | [3] D00359
D00359
,
D00850
(Name: MINOLIRA EXTENDED RELEASE),
D05045
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 206 206 |
97 | LPM3770164 sustained release tablet | [1] Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | [1] 8 8 |
98 | LPM3770164 sustained release tablet simulant | [1] Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | [1] 8 8 |
99 | LT-02 (modified-release PC pellets) | [1] Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | [1] 97 97 |
100 | LY03003 ( Rotigotine, extended-release microspheres) | [1] Rotigotine Rotigotine | [1] D05768
D05768
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
101 | LY03003 (rotigotine extended release microspheres for intramuscular [IM] injection) | [1] Rotigotine Rotigotine | [1] D05768
D05768
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
102 | LY03003(Rotigotine,extended-release microspheres) | [1] Rotigotine Rotigotine | [1] D05768
D05768
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
103 | Mesalamine Delayed Release Tablets 400mg | [2] Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | [1] D00377
D00377
| - | - | [1] 97 97 |
104 | Mesalazine slow-release granules | [1] Mesalazine Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | [1] D00377
D00377
| - | - | [1] 97 97 |
105 | Mesalazine Sustained-Release Tablets | [1] Mesalazine Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | [1] D00377
D00377
| - | - | [1] 96 96 |
106 | Metformin (Synonym: METFORMIN HYDROCHLORIDE EXTENDED RELEASE) | [1] Metformin Metformin (Synonym: Metformin Hydrochloride Extended Release) | [2] D00944
D00944
(Name: METFORMIN HYDROCHLORIDE EXTENDED RELEASE),
D04966
| [2] PRKAA1 PRKAA1, PRKAA2 💬 | [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [24] 2 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 |
107 | Metformin (generic) (Synonym: METFORMIN HYDROCHLORIDE EXTENDED RELEASE) | [1] Metformin Metformin (Synonym: Metformin Hydrochloride Extended Release) | [2] D00944
D00944
(Name: METFORMIN HYDROCHLORIDE EXTENDED RELEASE),
D04966
| [2] PRKAA1 PRKAA1, PRKAA2 💬 | [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [1] 158 158 |
108 | Metformin 500 mg TID Oral Tablet (Synonym: METFORMIN HYDROCHLORIDE EXTENDED RELEASE) | [1] Metformin Metformin (Synonym: Metformin Hydrochloride Extended Release) | [2] D00944
D00944
(Name: METFORMIN HYDROCHLORIDE EXTENDED RELEASE),
D04966
| [2] PRKAA1 PRKAA1, PRKAA2 💬 | [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [1] 97 97 |
109 | Metformin 500mg (Synonym: METFORMIN HYDROCHLORIDE EXTENDED RELEASE) | [1] Metformin Metformin (Synonym: Metformin Hydrochloride Extended Release) | [2] D00944
D00944
(Name: METFORMIN HYDROCHLORIDE EXTENDED RELEASE),
D04966
| [2] PRKAA1 PRKAA1, PRKAA2 💬 | [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [1] 113 113 |
110 | Metformin and Metformin & L-Citrulline (Synonym: METFORMIN HYDROCHLORIDE EXTENDED RELEASE) | [2] Citrulline Citrulline, Metformin (Synonym: Metformin Hydrochloride Extended Release) | [3] D00944
D00944
(Name: METFORMIN HYDROCHLORIDE EXTENDED RELEASE),
D04966
,
D07706
| [2] PRKAA1 PRKAA1, PRKAA2 💬 | [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [1] 113 113 |
111 | Metformin HCl (Synonym: METFORMIN HYDROCHLORIDE EXTENDED RELEASE) | [1] Metformin Metformin (Synonym: Metformin Hydrochloride Extended Release) | [2] D00944
D00944
(Name: METFORMIN HYDROCHLORIDE EXTENDED RELEASE),
D04966
| [2] PRKAA1 PRKAA1, PRKAA2 💬 | [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [1] 285 285 |
112 | METFORMIN HYDROCHLORIDE (Synonym: METFORMIN HYDROCHLORIDE EXTENDED RELEASE) | [1] Metformin Metformin (Synonym: Metformin Hydrochloride Extended Release) | [2] D00944
D00944
(Name: METFORMIN HYDROCHLORIDE EXTENDED RELEASE),
D04966
| [2] PRKAA1 PRKAA1, PRKAA2 💬 | [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [5] 81 81, 158, 265, 299, 301 |
113 | Metformin treatment (Synonym: METFORMIN HYDROCHLORIDE EXTENDED RELEASE) | [1] Metformin Metformin (Synonym: Metformin Hydrochloride Extended Release) | [2] D00944
D00944
(Name: METFORMIN HYDROCHLORIDE EXTENDED RELEASE),
D04966
| [2] PRKAA1 PRKAA1, PRKAA2 💬 | [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [1] 46 46 |
114 | Metformin XR (Synonym: METFORMIN HYDROCHLORIDE EXTENDED RELEASE) | [1] Metformin Metformin (Synonym: Metformin Hydrochloride Extended Release) | [2] D00944
D00944
(Name: METFORMIN HYDROCHLORIDE EXTENDED RELEASE),
D04966
| [2] PRKAA1 PRKAA1, PRKAA2 💬 | [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [1] 67 67 |
115 | Metformin/CP-690,550 (Synonym: METFORMIN HYDROCHLORIDE EXTENDED RELEASE) | [1] Metformin Metformin (Synonym: Metformin Hydrochloride Extended Release) | [2] D00944
D00944
(Name: METFORMIN HYDROCHLORIDE EXTENDED RELEASE),
D04966
| [2] PRKAA1 PRKAA1, PRKAA2 💬 | [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [1] 46 46 |
116 | Methylphenidate (Synonym: METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE) | [1] Methylphenidate Methylphenidate (Synonym: JORNAY PM Extended-Release) | [2] D01296
D01296
(Name: METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),
D04999
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [7] 6 6, 13, 34, 84, 113, 179, 206 |
117 | Methylphenidate (MPD) (Synonym: METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE) | [1] Methylphenidate Methylphenidate (Synonym: JORNAY PM Extended-Release) | [2] D01296
D01296
(Name: METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),
D04999
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 6 6 |
118 | Methylphenidate (overencapsulated) (Synonym: METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE) | [1] Methylphenidate Methylphenidate (Synonym: JORNAY PM Extended-Release) | [2] D01296
D01296
(Name: METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),
D04999
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 84 84 |
119 | Methylphenidate 10mg tablets (Synonym: METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE) | [1] Methylphenidate Methylphenidate (Synonym: JORNAY PM Extended-Release) | [2] D01296
D01296
(Name: METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),
D04999
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 84 84 |
120 | METHYLPHENIDATE HYDROCHLORIDE (Synonym: METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE) | [1] Methylphenidate Methylphenidate (Synonym: JORNAY PM Extended-Release) | [2] D01296
D01296
(Name: METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),
D04999
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [2] 6 6, 13 |
121 | Methylphenidate modified release | [1] Methylphenidate Methylphenidate (Synonym: JORNAY PM Extended-Release) | [2] D01296
D01296
(Name: METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),
D04999
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 13 13 |
122 | Methylphenidate modified release 20 mg | [1] Methylphenidate Methylphenidate (Synonym: JORNAY PM Extended-Release) | [2] D01296
D01296
(Name: METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),
D04999
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 13 13 |
123 | Methylphenidate modified release 30 mg | [1] Methylphenidate Methylphenidate (Synonym: JORNAY PM Extended-Release) | [2] D01296
D01296
(Name: METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),
D04999
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 13 13 |
124 | Methylphenidate modified release 40 mg | [1] Methylphenidate Methylphenidate (Synonym: JORNAY PM Extended-Release) | [2] D01296
D01296
(Name: METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),
D04999
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 13 13 |
125 | Methylphenidate, fluoxetin, risperidone (Synonym: METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE) | [3] Fluoxetine Fluoxetine, Methylphenidate (Synonym: JORNAY PM Extended-Release), Risperidone | [5] D00326
D00326
,
D00426
,
D00823
,
D01296
(Name: METHYLPHENIDATE HYDROCHLORIDE EXTENDED RELEASE),
D04999
| [5] DRD2 DRD2, HTR2A, SLC6A2, SLC6A3, SLC6A4 💬 | [14] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Rap1 signaling pathway, Serotonergic synapse, Synaptic vesicle cycle, cAMP signaling pathway 💬 | [2] 179 179, 206 |
126 | Mezavant Gastro-resistant, prolonged release tablets | [2] Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | [1] D00377
D00377
| - | - | [1] 97 97 |
127 | Mezavant XL 1200 mg gastro-resistant prolonged release tablets | [2] Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | [1] D00377
D00377
| - | - | [1] 97 97 |
128 | Mezavant XL 1200 mg gastro-resistant, prolonged release tablets | [2] Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | [1] D00377
D00377
| - | - | [1] 97 97 |
129 | Mezavant XL 1200 mg gastro-resistant, prolonged release tablets. | [2] Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | [1] D00377
D00377
| - | - | [1] 97 97 |
130 | Mezavant XL 1200mg gastro-resistant, prolonged release tablets | [2] Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | [1] D00377
D00377
| - | - | [1] 97 97 |
131 | Mezavant XL Gastro-resistant, prolonged release tablets | [2] Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | [1] D00377
D00377
| - | - | [1] 97 97 |
132 | MG01CI extended-release tablet | [1] Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | [1] 206 206 |
133 | Minocycline (Synonym: MINOLIRA EXTENDED RELEASE) | [1] Minocycline Minocycline (Synonym: Minolira Extended Release) | [2] D00850
D00850
(Name: MINOLIRA EXTENDED RELEASE),
D05045
| - | - | [13] 2 2, 6, 8, 13, 46, 85, 90, 94, 162, 201, 206, 280, 299 |
134 | Minocycline 100 mg Film-coated Tablets (Synonym: MINOLIRA EXTENDED RELEASE) | [1] Minocycline Minocycline (Synonym: Minolira Extended Release) | [2] D00850
D00850
(Name: MINOLIRA EXTENDED RELEASE),
D05045
| - | - | [1] 13 13 |
135 | Minocycline 100mg (Synonym: MINOLIRA EXTENDED RELEASE) | [1] Minocycline Minocycline (Synonym: Minolira Extended Release) | [2] D00850
D00850
(Name: MINOLIRA EXTENDED RELEASE),
D05045
| - | - | [1] 13 13 |
136 | Minocycline Hydrochloride (Synonym: MINOLIRA EXTENDED RELEASE) | [1] Minocycline Minocycline (Synonym: Minolira Extended Release) | [2] D00850
D00850
(Name: MINOLIRA EXTENDED RELEASE),
D05045
| - | - | [4] 13 13, 201, 206, 299 |
137 | Minocycline, then Minocycline/Lovastatin (Synonym: MINOLIRA EXTENDED RELEASE) | [2] Lovastatin Lovastatin, Minocycline (Synonym: Minolira Extended Release) | [3] D00359
D00359
,
D00850
(Name: MINOLIRA EXTENDED RELEASE),
D05045
| [1] HMGCR HMGCR 💬 | [4] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | [1] 206 206 |
138 | Mirapexin extended release various strengths | [2] Manganese citrate Manganese citrate (Synonym: Release), Pramipexole (Synonym: Pramipexole Dihydrochloride Extended-Release) | [2] D00559
D00559
,
D05575
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
139 | Modified-release phosphatidylcholine | [2] Lecithin Lecithin, Manganese citrate (Synonym: Release) | [1] D04682
D04682
| - | - | [1] 97 97 |
140 | Nalbuphine Extended-Release (ER) Tablets | [1] Nalbuphine Nalbuphine | [2] D00843
D00843
,
D08246
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 85 85 |
141 | Naproxen (EC-Narosyn) Delayed Release Tables, 375 (Syntex (USA), Inc.) | [1] Naproxen Naproxen (Synonym: Naproxen Delayed-release) | [1] D00118
D00118
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 |
142 | Naproxen Delayed Release Tables, 375 (Gevena Pharmaceuticals, Inc.) | [1] Naproxen Naproxen (Synonym: Naproxen Delayed-release) | [1] D00118
D00118
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 46 46 |
143 | Octreotide LAR / Sandostatin LAR (LAR=long acting release) | [1] Octreotide Octreotide | [2] D00442
D00442
,
D06495
| [1] SSTR2 SSTR2 💬 | [4] Gastric acid secretion Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 84 84 |
144 | Oral treprostinil (UT-15C) Sustained Release Tablets | [1] Treprostinil Treprostinil | [1] D06213
D06213
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 86 86 |
145 | Other: Metformin (Synonym: METFORMIN HYDROCHLORIDE EXTENDED RELEASE) | [1] Metformin Metformin (Synonym: Metformin Hydrochloride Extended Release) | [2] D00944
D00944
(Name: METFORMIN HYDROCHLORIDE EXTENDED RELEASE),
D04966
| [2] PRKAA1 PRKAA1, PRKAA2 💬 | [20] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [1] 46 46 |
146 | Oxybutynin, tolterodine, solifenacin (Synonym: TOLTERODINE TARTRATE EXTENDED RELEASE) | [3] Oxybutynin Oxybutynin (Synonym: Oxybutynin ChlorideExtended Release Extended Release), Solifenacin, Tolterodine (Synonym: Tolterodine Tartrate Extended Release) | [6] D00465
D00465
,
D00646
,
D00722
,
D01148
(Name: TOLTERODINE TARTRATE EXTENDED RELEASE),
D01269
,
D08522
| [5] CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | [13] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | [1] 53 53 |
147 | Oxycodone naloxone prolonged release tablets | [2] Naloxone Naloxone, Oxycodone (Synonym: Oxycodone HCl Controlled-Release) | [5] D01340
D01340
,
D03783
,
D05312
,
D05462
,
D08249
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 |
148 | Oxycodone/naloxone prolonged release t | [3] Manganese citrate Manganese citrate (Synonym: Release), Naloxone, Oxycodone (Synonym: Oxycodone HCl Controlled-Release) | [5] D01340
D01340
,
D03783
,
D05312
,
D05462
,
D08249
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 |
149 | Oxycodone/Naloxone Prolonged Release tablets | [2] Naloxone Naloxone, Oxycodone (Synonym: Oxycodone HCl Controlled-Release) | [5] D01340
D01340
,
D03783
,
D05312
,
D05462
,
D08249
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 |
150 | Oxycodone/naloxone prolonged release tablets 10 mg /5 mg | [3] Manganese citrate Manganese citrate (Synonym: Release), Naloxone, Oxycodone (Synonym: Oxycodone HCl Controlled-Release) | [5] D01340
D01340
,
D03783
,
D05312
,
D05462
,
D08249
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 |
151 | Oxycodone/naloxone prolonged release tablets 10/5 mg | [3] Manganese citrate Manganese citrate (Synonym: Release), Naloxone, Oxycodone (Synonym: Oxycodone HCl Controlled-Release) | [5] D01340
D01340
,
D03783
,
D05312
,
D05462
,
D08249
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 |
152 | Oxycodone/naloxone prolonged release tablets 20 mg /10 mg | [3] Manganese citrate Manganese citrate (Synonym: Release), Naloxone, Oxycodone (Synonym: Oxycodone HCl Controlled-Release) | [5] D01340
D01340
,
D03783
,
D05312
,
D05462
,
D08249
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 |
153 | Oxycodone/naloxone prolonged release tablets 20/10 mg | [3] Manganese citrate Manganese citrate (Synonym: Release), Naloxone, Oxycodone (Synonym: Oxycodone HCl Controlled-Release) | [5] D01340
D01340
,
D03783
,
D05312
,
D05462
,
D08249
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 |
154 | Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg | [3] Manganese citrate Manganese citrate (Synonym: Release), Naloxone, Oxycodone (Synonym: Oxycodone HCl Controlled-Release) | [5] D01340
D01340
,
D03783
,
D05312
,
D05462
,
D08249
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 6 6 |
155 | Oxycodone/naloxone prolonged release tablets 5/2.5 mg | [3] Manganese citrate Manganese citrate (Synonym: Release), Naloxone, Oxycodone (Synonym: Oxycodone HCl Controlled-Release) | [5] D01340
D01340
,
D03783
,
D05312
,
D05462
,
D08249
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 |
156 | Pancrelipase Delayed Release | [1] Pancrelipase Pancrelipase | [1] D05349
D05349
| - | - | [1] 299 299 |
157 | Pancrelipase Delayed Release Capsule | [1] Pancrelipase Pancrelipase | [1] D05349
D05349
| - | - | [2] 298 298, 299 |
158 | Pentasa 2g sachet prolonged release granules (95%) | [2] Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | [1] D00377
D00377
| - | - | [1] 97 97 |
159 | Pentasa Compact 2g, granulate with prolonged release | [2] Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | [1] D00377
D00377
| - | - | [1] 97 97 |
160 | Pentasa Compact 4g, granulate with prolonged release | [2] Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | [1] D00377
D00377
| - | - | [1] 97 97 |
161 | Pentasa prolonged release granules 2g | [2] Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | [1] D00377
D00377
| - | - | [1] 97 97 |
162 | Pentasa Sachet 1 g prolonged release granules | [2] Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | [1] D00377
D00377
| - | - | [1] 96 96 |
163 | Pioglitazone or metformin (Synonym: METFORMIN HYDROCHLORIDE EXTENDED RELEASE) | [2] Metformin Metformin (Synonym: Metformin Hydrochloride Extended Release), Pioglitazone | [4] D00944
D00944
(Name: METFORMIN HYDROCHLORIDE EXTENDED RELEASE),
D00945
,
D04966
,
D08378
| [3] PPARG PPARG, PRKAA1, PRKAA2 💬 | [27] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Huntington disease, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Osteoclast differentiation, Oxytocin signaling pathway, PI3K-Akt signaling pathway, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Tight junction, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | [1] 265 265 |
164 | Plenadren 20 mg modified-release tablets | [2] Hydrocortisone Hydrocortisone, Manganese citrate (Synonym: Release) | [1] D00088
D00088
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 78 78 |
165 | Plenadren 5 mg modified-release tablets | [2] Hydrocortisone Hydrocortisone, Manganese citrate (Synonym: Release) | [1] D00088
D00088
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 78 78 |
166 | Posaconazole Delayed Release Oral Tablet | [1] Posaconazole Posaconazole | [1] D02555
D02555
| - | - | [1] 96 96 |
167 | Pramipexol Extended Release | [1] Pramipexole Pramipexole (Synonym: Pramipexole Dihydrochloride Extended-Release) | [2] D00559
D00559
,
D05575
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
168 | Pramipexol Immediate Release | [1] Pramipexole Pramipexole (Synonym: Pramipexole Dihydrochloride Extended-Release) | [2] D00559
D00559
,
D05575
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
169 | Pramipexole dihydrochloride extended-release tablets | [1] Pramipexole Pramipexole (Synonym: Pramipexole Dihydrochloride Extended-Release) | [2] D00559
D00559
,
D05575
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
170 | Pramipexole dihydrochloride monohydrate extended release | [2] Manganese citrate Manganese citrate (Synonym: Release), Pramipexole (Synonym: Pramipexole Dihydrochloride Extended-Release) | [2] D00559
D00559
,
D05575
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
171 | Pramipexole Extended Release | [1] Pramipexole Pramipexole (Synonym: Pramipexole Dihydrochloride Extended-Release) | [2] D00559
D00559
,
D05575
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
172 | Pramipexole extended release tablet | [1] Pramipexole Pramipexole (Synonym: Pramipexole Dihydrochloride Extended-Release) | [2] D00559
D00559
,
D05575
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
173 | Pramipexole hydrochloride sustained-release tablet (Siforl®) Specification: 0.26mg/ tablet (in pramipexole) | [1] Pramipexole Pramipexole (Synonym: Pramipexole Dihydrochloride Extended-Release) | [2] D00559
D00559
,
D05575
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
174 | Pramipexole Immediate Release | [1] Pramipexole Pramipexole (Synonym: Pramipexole Dihydrochloride Extended-Release) | [2] D00559
D00559
,
D05575
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
175 | Pramipexole immediate release tablet | [1] Pramipexole Pramipexole (Synonym: Pramipexole Dihydrochloride Extended-Release) | [2] D00559
D00559
,
D05575
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
176 | Praxol hydrochloride sustained release tablet Specification: 0.375mg/ tablet (in pramipexole hydrochloride) | [1] Pramipexole Pramipexole (Synonym: Pramipexole Dihydrochloride Extended-Release) | [2] D00559
D00559
,
D05575
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
177 | Pregabalin (Synonym: PREGABALIN EXTENDED RELEASE) | [1] Pregabalin Pregabalin (Synonym: Pregabalin Extended Release) | [1] D02716
D02716
(Name: PREGABALIN EXTENDED RELEASE) | [4] CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 | [7] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬 | [5] 13 13, 36, 46, 70, 298 |
178 | Pregabalin 75mg (Synonym: PREGABALIN EXTENDED RELEASE) | [1] Pregabalin Pregabalin (Synonym: Pregabalin Extended Release) | [1] D02716
D02716
(Name: PREGABALIN EXTENDED RELEASE) | [4] CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 | [7] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬 | [1] 70 70 |
179 | Prolonged release tablet | [1] Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | [1] 6 6 |
180 | Prolonged-release Fampridine | [1] Dalfampridine Dalfampridine | [1] D04127
D04127
| [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [1] 13 13 |
181 | Rabeprazole (Synonym: RABEPRAZOLE SODIUM DELAYED-RELEASE) | [1] Rabeprazole Rabeprazole (Synonym: Rabeprazole Sodium Delayed-release) | [2] D00724
D00724
(Name: RABEPRAZOLE SODIUM DELAYED-RELEASE),
D08463
| [2] ATP4A ATP4A, ATP4B 💬 | [4] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | [2] 2 2, 51 |
182 | Ranolazine PR (prolonged-release) 500 mg 1 tablet bis in die and 750 mg 1 tablet bis in die | [1] Ranolazine Ranolazine | [2] D05700
D05700
,
D05701
| - | - | [1] 58 58 |
183 | RAYOS (delayed-release prednisone) | [1] Prednisone Prednisone | [1] D00473
D00473
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 46 46 |
184 | Release | [1] Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | [12] 6 6, 8, 13, 46, 65, 78, 81, 96, 97, 206, 226, 299 |
185 | Requip prolonged release | [2] Manganese citrate Manganese citrate (Synonym: Release), Ropinirole | [2] D00784
D00784
,
D08489
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
186 | Requip XL prolonged-release | [2] Manganese citrate Manganese citrate (Synonym: Release), Ropinirole | [2] D00784
D00784
,
D08489
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
187 | Retarded release phosphatidylcholine | [1] Lecithin Lecithin | [1] D04682
D04682
| - | - | [1] 97 97 |
188 | Retarded Release Phosphatidylcholine (rPC) | [1] Lecithin Lecithin | [1] D04682
D04682
| - | - | [1] 97 97 |
189 | Rifaximin Delayed Release (DR) | [1] Rifaximin Rifaximin | [1] D02554
D02554
| - | - | [1] 96 96 |
190 | Rifaximin delayed release 400 mg film coated tablet | [1] Rifaximin Rifaximin | [1] D02554
D02554
| - | - | [1] 96 96 |
191 | Rifaximin delayed release tablets | [1] Rifaximin Rifaximin | [1] D02554
D02554
| - | - | [1] 96 96 |
192 | Ropinirole controlled-release (REQUIP CR) for RLS | [1] Ropinirole Ropinirole | [2] D00784
D00784
,
D08489
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
193 | Ropinirole hydrochloride extended-release tablet | [1] Ropinirole Ropinirole | [2] D00784
D00784
,
D08489
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
194 | Ropinirole hydrochloride extended-release tablet placebo | [1] Ropinirole Ropinirole | [2] D00784
D00784
,
D08489
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
195 | Ropinirole hydrochloride prolonged release | [2] Manganese citrate Manganese citrate (Synonym: Release), Ropinirole | [2] D00784
D00784
,
D08489
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
196 | Ropinirole immediate release | [1] Ropinirole Ropinirole | [2] D00784
D00784
,
D08489
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
197 | Ropinirole Prolonged release | [1] Ropinirole Ropinirole | [2] D00784
D00784
,
D08489
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
198 | Ropinirole prolonged release/extended release(PR/XR) | [1] Ropinirole Ropinirole | [2] D00784
D00784
,
D08489
| [3] DRD2 DRD2, DRD3, DRD4 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
199 | Rosiglitazone Extended Release Tablets | [1] Rosiglitazone Rosiglitazone | [2] D00596
D00596
,
D08491
| [1] PPARG PPARG 💬 | [11] AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 46 46 |
200 | Rotigotine, extended-release microspheres | [1] Rotigotine Rotigotine | [1] D05768
D05768
| [1] DRD2 DRD2 💬 | [8] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
201 | Salofalk 3g gastro-resistant prolonged-release granules | [2] Manganese citrate Manganese citrate (Synonym: Release), Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | [1] D00377
D00377
| - | - | [1] 97 97 |
202 | Sinemet CR 25Mg-100Mg Extended-Release Tablet | [3] Carbidopa Carbidopa, Levodopa, Manganese citrate (Synonym: Release) | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
203 | Sinemet® controlled release (Carbidopa/levodopa) | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [1] 6 6 |
204 | Sitagliptin and Metformin (Synonym: METFORMIN HYDROCHLORIDE EXTENDED RELEASE) | [2] Metformin Metformin (Synonym: Metformin Hydrochloride Extended Release), Sitagliptin | [3] D00944
D00944
(Name: METFORMIN HYDROCHLORIDE EXTENDED RELEASE),
D04966
,
D08516
| [3] DPP4 DPP4, PRKAA1, PRKAA2 💬 | [21] AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Protein digestion and absorption, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | [1] 233 233 |
205 | SPD476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine | [1] Mesalazine Mesalazine (Synonym: Pentasa Extended-release Tablets 250mg) | [1] D00377
D00377
| - | - | [1] 97 97 |
206 | Sustained release growth hormone | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
207 | Sustained-release oral dalfampridine | [1] Dalfampridine Dalfampridine | [1] D04127
D04127
| [4] KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | [4] Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | [1] 13 13 |
208 | Sustained-release recombinant human GH (SR-rhGH) | [1] Somatotropin Somatotropin | [1] D02691
D02691
| [1] GHR GHR 💬 | [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | [1] 78 78 |
209 | Tacrolimus prolonged-release hard capsules | [2] Manganese citrate Manganese citrate (Synonym: Release), Tacrolimus | [2] D00107
D00107
,
D08556
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 299 299 |
210 | Targinact 10 mg/5 mg prolonged-release tablets | [1] Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | [2] 6 6, 226 |
211 | Targinact 20 mg/10 mg prolonged-release tablets | [1] Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | [1] 6 6 |
212 | Targinact 20mg/10 mg prolonged-release tablets | [1] Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | [1] 226 226 |
213 | Targinact 5 mg/2.5 mg prolonged-release tablets | [1] Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | [1] 6 6 |
214 | Targinact 5mg/2.5 mg prolonged-release tablets | [1] Manganese citrate Manganese citrate (Synonym: Release) | - | - | - | [1] 226 226 |
215 | Tofacitinib (Xeljanz®) 11mg Prolonged Release Tablet | [1] Tofacitinib Tofacitinib | [1] D09970
D09970
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬 | [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 46 46 |
216 | Tolterodine (Synonym: TOLTERODINE TARTRATE EXTENDED RELEASE) | [1] Tolterodine Tolterodine (Synonym: Tolterodine Tartrate Extended Release) | [2] D00646
D00646
,
D01148
(Name: TOLTERODINE TARTRATE EXTENDED RELEASE) | [1] CHRM3 CHRM3 💬 | [11] Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | [2] 17 17, 53 |
217 | WD-1603 CARBIDOPA and LEVODOPA EXTENDED-RELEASE TABLETS | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
218 | WD-1603 Carbidopa-Levodopa Extended-Release Tablets | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
219 | WD-1603 CARBIDOPA/LEVODOPA EXTENDED-RELEASE TABLETS | [2] Carbidopa Carbidopa, Levodopa | [2] D00059
D00059
,
D00558
| [6] DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [16] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | [1] 6 6 |
220 | Wellbutrin (bupropion) (Synonym: BUPROPION HYDROCHLORIDE EXTENDED RELEASE) | [1] Bupropion Bupropion (Synonym: Contrave Extended-Release) | [3] D00817
D00817
(Name: BUPROPION HYDROCHLORIDE EXTENDED RELEASE),
D07591
,
D07938
| [2] SLC6A2 SLC6A2, SLC6A3 💬 | [7] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | [1] 96 96 |
221 | Xeljanz® 11mg Prolonged Release Tablet | [2] Manganese citrate Manganese citrate (Synonym: Release), Tofacitinib | [1] D09970
D09970
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬 | [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [1] 46 46 |